Literature DB >> 6605688

Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.

B F Burns, R A Warnke, R S Doggett, R V Rouse.   

Abstract

The Leu-1 antigen has been defined by monoclonal antibodies (L17F12, T101, and OKT-1) as a pan-T-cell antigen present on all human peripheral blood T cells and thymocytes. Although originally thought to be confined to T-cell lineage, some cases of B-cell chronic lymphocytic leukemia have been found to react with these antibodies. Using a frozen section immunoperoxidase staining technique, 125 lymphomas with B-cell differentiation were examined for the presence of Leu-1 antigen. Leu-1 antigen was detected in 4 of 11 cases of diffuse small lymphocytic lymphoma (Rappaport's DWDL) and 3 of 4 cases of diffuse intermediate lymphocytic lymphoma. Follicular lymphomas less often expressed this antigen--2 of 29 cases of the small cleaved cell type (Rappaport's NPDL), none of 13 cases of mixed small cleaved and large cell type (Rappaport's NM), and 1 of 6 cases of large cell type (Rappaport's NH). Diffuse lymphomas of presumed follicular center cell origin expressed this antigen infrequently as well--1 of 3 cases of the small cleaved cell type (Rappaport's DPDL), neither of 2 cases of mixed small cleaved and large cell type (Rappaport's DM), and 3 of 43 of large cell type (cleaved/noncleaved) (Rappaport's DH). Diffuse large cell, immunoblastic lymphoma of B-cell type expressed Leu-1 in 1 of 6 cases. None of the 3 cases of Burkitt's lymphoma or of the three small noncleaved non-Burkitt's lymphoma (Rappaport's undifferentiated) expressed detectable Leu-1. B-lymphoblastic lymphoma (1 case) and B-cell unclassified lymphoma (1 case) both failed to express detectable Leu-1. It appears that this pan-T-cell antigen is mainly found on those B-cell lymphomas composed predominantly of small lymphocytes. This finding may be of use in distinguishing extranodal neoplastic collections of small lymphocytes from lymphocytic hyperplasias.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605688      PMCID: PMC1916369     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

2.  A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation.

Authors:  F D Howard; J A Ledbetter; J Wong; C P Bieber; E B Stinson; L A Herzenberg
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

3.  Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.

Authors:  E G Engleman; R Warnke; R I Fox; J Dilley; C J Benike; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

4.  Initial characterization of monoclonal antibodies against human monocytes.

Authors:  V Ugolini; G Nunez; R G Smith; P Stastny; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

5.  A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.

Authors:  M Kamoun; M E Kadin; P J Martin; J Nettleton; J A Hansen
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Comparative density of the human T-cell antigen T65 on normal peripheral blood T cells and chronic lymphocytic leukemia cells.

Authors:  S B Wormsley; M L Collins; I Royston
Journal:  Blood       Date:  1981-04       Impact factor: 22.113

7.  Expression of Lyt-1 antigen on certain murine B cell lymphomas.

Authors:  L L Lanier; N L Warner; J A Ledbetter; L A Herzenberg
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

8.  An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells.

Authors:  L Boumsell; H Coppin; D Pham; B Raynal; J Lemerle; J Dausset; A Bernard
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

9.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man.

Authors:  J A Ledbetter; R L Evans; M Lipinski; C Cunningham-Rundles; R A Good; L A Herzenberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

10.  Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells.

Authors:  C Y Wang; R A Good; P Ammirati; G Dymbort; R L Evans
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  19 in total

1.  Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy.

Authors:  Sukjoong Oh; Dong Hoe Koo; Cheolwon Suh; Shin Kim; Bong Hee Park; Joon Kang; Jooryung Huh
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

2.  Tonsillar mapping of determinants found on normal lymphoreticular (T,B,K, immature and macrophage) and myeloblastic leukemia cells.

Authors:  E M McMillan; L Stoneking; G B Humphrey; J Rapacz
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

Review 3.  Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.

Authors:  L J Picker; L M Weiss; L J Medeiros; G S Wood; R A Warnke
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

4.  CD5+ diffuse large B-cell lymphoma with hemophagocytosis.

Authors:  Jan K Davidson-Moncada; Emily McDuffee; Mark Roschewski
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

5.  Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease.

Authors:  W Timens; S Poppema
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

6.  De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

Authors:  A Matolcsy; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

7.  Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.

Authors:  N L Harris; L M Nadler; A K Bhan
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

8.  Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.

Authors:  E Ralfkiaer; T A Saati; J Bosq; G Delsol; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

9.  Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).

Authors:  T Al Saati; G Laurent; P Caveriviere; F Rigal; G Delsol
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

10.  Membrane phenotypic studies in B cell lymphoproliferative disorders.

Authors:  C S Scott; H J Limbert; I D MacKarill; B E Roberts
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.